英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

whitish    音标拼音: [w'ɑɪtɪʃ] [hw'ɑɪtɪʃ]
a. 发白的,带白色的

发白的,带白色的

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • ESCC and GC GEJC Treatment | TEVIMBRA® (tislelizumab-jsgr)
    TEVIMBRA is a prescription medicine used to treat adults with: cancer of the tube that connects your throat to your stomach (esophageal cancer) TEVIMBRA may be used in combination with chemotherapy that contains platinum as your first treatment when your esophageal cancer: is a type called squamous cell carcinoma, and cannot be removed with surgery or has spread to other parts of the body
  • TEVIMBRA Approved in U. S. for First-line Treatment of Gastric . . .
    TEVIMBRA Approved in U S for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy Dec 27, 2024 6:00 AM
  • label - accessdata. fda. gov
    1 2 Gastric Cancer TEVIMBRA, in combination with platinum and fluoropyrimidine-based chemotherapy, is indicated for the first-line treatment of adults with unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma (G GEJ) whose tumors express PD-L1 ( 1) 2
  • FDA Approves Tislelizumab Plus Chemo for PD-L1+ Unresectable . . .
    Key Takeaways Tislelizumab-jsgr (Tevimbra) approved for first-line treatment of HER2-negative gastric or GEJ adenocarcinoma with PD-L1 expression Phase 3 RATIONALE-305 trial showed significant
  • Tislelizumab (Tevimbra): Uses in Cancer, Side Effects, Dosage . . .
    Tislelizumab (Tevimbra) is a PD-1 inhibitor monoclonal antibody designed to enhance the immune system’s ability to fight cancer It has received several approvals for treating various cancers In the U S , the FDA approved Tevimbra in combination with chemotherapy for the first-line treatment of unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ
  • FDA Approves Tevimbra Combination for Gastric or . . .
    A drug called Tevimbra (tislelizumab-jsgr) has been approved for use with chemotherapy as first-line treatment of PD-L1 positive unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma Tevimbra was approved earlier in 2024 to treat unresectable or metastatic esophageal squamous cell carcinoma
  • FDA Approves Tislelizumab-jsgr (Tevimbra) Combo for Gastric . . .
    The U S Food and Drug Administration approved tislelizumab-jsgr (Tevimbra) in combination with chemotherapy as a first-line treatment for adults with unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinomas whose tumors express PD-L1
  • Tislelizumab Approval Gastric Cancer Treatment
    The FDA has approved tislelizumab (Tevimbra, BeiGene), in combination with platinum and fluoropyrimidine-based chemotherapy, for the first-line treatment of unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma (G GEJ) cancers in adults whose tumors express PD-L1 (programmed death ligand-1) (≥1)
  • FDA Approves Tislelizumab-jsgr as First-Line Therapy for HER2 . . .
    Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic HER2-negative (HER–) gastric or gastroesophageal junction
  • Tevimbra by BeiGene approved in US for initial gastric cancer . . .
    BeiGene has received approval from the US Food and Drug Administration (FDA) for its PD-1 inhibitor, Tevimbra (tislelizumab), to be used in combination with chemotherapy for the treatment of advanced gastric or gastroesophageal junction (G GEJ) adenocarcinoma





中文字典-英文字典  2005-2009